Not sure if you are aware of this, but these studies cost millions and millions of dollars. Most up and coming Biotechs tend to be in the red and people this find attractive, because of the huge upside potential when the drugs get approved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.